496 related articles for article (PubMed ID: 33596235)
41. Biochemical analysis of SARS-CoV-2 Nsp13 helicase implicated in COVID-19 and factors that regulate its catalytic functions.
Sommers JA; Loftus LN; Jones MP; Lee RA; Haren CE; Dumm AJ; Brosh RM
J Biol Chem; 2023 Mar; 299(3):102980. PubMed ID: 36739951
[TBL] [Abstract][Full Text] [Related]
42. Cheminformatics approach to identify andrographolide derivatives as dual inhibitors of methyltransferases (nsp14 and nsp16) of SARS-CoV-2.
Thomas J; Ghosh A; Ranjan S; Satija J
Sci Rep; 2024 Apr; 14(1):9801. PubMed ID: 38684706
[TBL] [Abstract][Full Text] [Related]
43. Ensemble cryo-EM reveals conformational states of the nsp13 helicase in the SARS-CoV-2 helicase replication-transcription complex.
Chen J; Wang Q; Malone B; Llewellyn E; Pechersky Y; Maruthi K; Eng ET; Perry JK; Campbell EA; Shaw DE; Darst SA
Nat Struct Mol Biol; 2022 Mar; 29(3):250-260. PubMed ID: 35260847
[TBL] [Abstract][Full Text] [Related]
44. Repurposing nonnucleoside antivirals against SARS-CoV2 NSP12 (RNA dependent RNA polymerase): In silico-molecular insight.
Begum F; Srivastava AK; Ray U
Biochem Biophys Res Commun; 2021 Sep; 571():26-31. PubMed ID: 34303192
[TBL] [Abstract][Full Text] [Related]
45. Force-dependent stimulation of RNA unwinding by SARS-CoV-2 nsp13 helicase.
Mickolajczyk KJ; Shelton PMM; Grasso M; Cao X; Warrington SE; Aher A; Liu S; Kapoor TM
Biophys J; 2021 Mar; 120(6):1020-1030. PubMed ID: 33340543
[TBL] [Abstract][Full Text] [Related]
46. Targeting novel structural and functional features of coronavirus protease nsp5 (3CL
Roe MK; Junod NA; Young AR; Beachboard DC; Stobart CC
J Gen Virol; 2021 Mar; 102(3):. PubMed ID: 33507143
[TBL] [Abstract][Full Text] [Related]
47. Genetic conservation of SARS-CoV-2 RNA replication complex in globally circulating isolates and recently emerged variants from humans and minks suggests minimal pre-existing resistance to remdesivir.
Martin R; Li J; Parvangada A; Perry J; Cihlar T; Mo H; Porter D; Svarovskaia E
Antiviral Res; 2021 Apr; 188():105033. PubMed ID: 33549572
[TBL] [Abstract][Full Text] [Related]
48.
Gurung AB
Gene Rep; 2020 Dec; 21():100860. PubMed ID: 32875166
[TBL] [Abstract][Full Text] [Related]
49. In Silico Insights towards the Identification of SARS-CoV-2 NSP13 Helicase Druggable Pockets.
Ricci F; Gitto R; Pitasi G; De Luca L
Biomolecules; 2022 Mar; 12(4):. PubMed ID: 35454070
[TBL] [Abstract][Full Text] [Related]
50.
Mateev E; Georgieva M; Zlatkov A
Comb Chem High Throughput Screen; 2023; 26(6):1242-1250. PubMed ID: 35984023
[TBL] [Abstract][Full Text] [Related]
51. Punicalagin as an allosteric NSP13 helicase inhibitor potently suppresses SARS-CoV-2 replication in vitro.
Lu L; Peng Y; Yao H; Wang Y; Li J; Yang Y; Lin Z
Antiviral Res; 2022 Oct; 206():105389. PubMed ID: 35985407
[TBL] [Abstract][Full Text] [Related]
52. An Overview of the Crystallized Structures of the SARS-CoV-2.
Ionescu MI
Protein J; 2020 Dec; 39(6):600-618. PubMed ID: 33098476
[TBL] [Abstract][Full Text] [Related]
53. Identification of FDA approved drugs against SARS-CoV-2 RNA dependent RNA polymerase (RdRp) and 3-chymotrypsin-like protease (3CLpro), drug repurposing approach.
Molavi Z; Razi S; Mirmotalebisohi SA; Adibi A; Sameni M; Karami F; Niazi V; Niknam Z; Aliashrafi M; Taheri M; Ghafouri-Fard S; Jeibouei S; Mahdian S; Zali H; Ranjbar MM; Yazdani M
Biomed Pharmacother; 2021 Jun; 138():111544. PubMed ID: 34311539
[TBL] [Abstract][Full Text] [Related]
54. Site mapping and small molecule blind docking reveal a possible target site on the SARS-CoV-2 main protease dimer interface.
Liang J; Karagiannis C; Pitsillou E; Darmawan KK; Ng K; Hung A; Karagiannis TC
Comput Biol Chem; 2020 Dec; 89():107372. PubMed ID: 32911432
[TBL] [Abstract][Full Text] [Related]
55. Targeting SARS-CoV-2 Proteases and Polymerase for COVID-19 Treatment: State of the Art and Future Opportunities.
Cannalire R; Cerchia C; Beccari AR; Di Leva FS; Summa V
J Med Chem; 2022 Feb; 65(4):2716-2746. PubMed ID: 33186044
[TBL] [Abstract][Full Text] [Related]
56. Deducing the Crystal Structure of MERS-CoV Helicase.
Cui S; Hao W
Methods Mol Biol; 2020; 2099():69-85. PubMed ID: 31883088
[TBL] [Abstract][Full Text] [Related]
57. The Coronavirus helicase in replication.
Grimes SL; Denison MR
Virus Res; 2024 Aug; 346():199401. PubMed ID: 38796132
[TBL] [Abstract][Full Text] [Related]
58. Phytochemicals from Selective Plants Have Promising Potential against SARS-CoV-2: Investigation and Corroboration through Molecular Docking, MD Simulations, and Quantum Computations.
Kousar K; Majeed A; Yasmin F; Hussain W; Rasool N
Biomed Res Int; 2020; 2020():6237160. PubMed ID: 33102585
[TBL] [Abstract][Full Text] [Related]
59. An atomistic model of the coronavirus replication-transcription complex as a hexamer assembled around nsp15.
Perry JK; Appleby TC; Bilello JP; Feng JY; Schmitz U; Campbell EA
J Biol Chem; 2021 Oct; 297(4):101218. PubMed ID: 34562452
[TBL] [Abstract][Full Text] [Related]
60. Research Progress on Spike-Dependent SARS-CoV-2 Fusion Inhibitors and Small Molecules Targeting the S2 Subunit of Spike.
Freidel MR; Armen RS
Viruses; 2024 Apr; 16(5):. PubMed ID: 38793593
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
